<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>kyrock85</b></i> I participated in the study (i'm homozygous df508). In the begining I wasn't suppose to be able to see what my PFTs were (they were pretty good about keepin that info hidden). I was on the drug from January 2010 until june 2011 when they pulled it for not showing enough significant data. I can tell you that when I had to try 2 times to get into the study. Like I said, for about 6 months I wasn't allowed to know what my PFTS were, but I can tell you that you that it was a whole heck of a lot easier to breath, I had decrease cough, my mucous was thinner, and I put on weight like it was job! After beign on the study for 6 months, I was switched to part B. To continue and switch to part b you had to meet one of 3 outcomes. Increase PFT by i believe 10%, change in sweat chlorides, and I forget the 3rd. I had a change in my sweat chloride. Once switched to part B, I could see my PFTS once again. My PFTs remainded stable ( and much improved from when I began the study). I went from getting clean outs from every 6 months to once a year and now it will have been 21 months on friday. SOOO, does this drug work on ddf508, somewhat. Does it need some kind of help yes.</end quote>
Interesting, to me what this means is that there is more to DDF508 and DF508 than we (the people) are being told. It must also have a gating component, or is it that Kalydeco does much more then just fix gating mutations?.... Too many variables.